Parathyroid Gland Weight is Associated with High Density Lipoprotein Levels in Patients with Primary Hyperparathyroidism

Overview

Journal J Clin Transl Endocrinol

Specialty Endocrinology

Date 2020 Jan 1

PMID 31890605

Citations 1

Authors

Aseel Al Dayyeni

Amar Mahdi

Yuling He

Stanley Z Trooskin

Lingqiong Meng

Xiangbing Wang

Affiliations

Soon will be listed here.

Abstract

Objective: To investigate the relationship between parathyroid gland weight and high-density lipoprotein (HDL) levels in patients with primary hyperparathyroidism (PHPT).

Methods: In this retrospective case control study, we reviewed 329 PHPT patients aged from 20 to 85 years who had a parathyroidectomy at Robert Wood Johnson University Hospital. The patients were divided into 5 quintiles according to their parathyroid gland weight: 68 patients had a parathyroid gland weight <0.3 g, 66 patients had a gland weight 0.3-0.45 g, 67 patients had a gland weight 0.45-0.7 g, 63 patients had a gland weight 0.7-1.25 g, and 65 patients had a gland weight ≥1.25 g.

Results: Body Mass Index (BMI) trended to be higher across the quintiles of parathyroid gland weight (P = 0.003). Serum calcium and PTH levels were significantly increased across parathyroid gland quintiles (p < 0.0001). HDL levels tended to be lower across the increasing quintiles of parathyroid gland weight (P = 0.01). There was a negative relationship between log parathyroid gland weight and HDL in patients with PHPT in a simple linear regression (r = -0.160, P = 0.003). The negative association remained significant after adjustment for age and BMI (r = -0.114, P = 0.039). Furthermore, parathyroid gland weight was significantly associated with levels of triglyceride (r = 0.126, P = 0.02), but this relationship lost its significance after adjustment for age and BMI (r = 0.082, P ˃ 0.05).

Conclusions: PHPT patients with heavier parathyroid glands tended to have higher BMI and lower HDL levels.

Citing Articles

The unique association between serum 25-hydroxyvitamin D concentrations and blood lipid profiles in agriculture, forestry, and fishing occupations: Insights from NHANES 2001-2014.

Zhang B, Dong X PLoS One. 2024; 19(2):e0297873.

PMID: 38412162 PMC: 10898752. DOI: 10.1371/journal.pone.0297873.

References

Han D, Trooskin S, Wang X . Prevalence of cardiovascular risk factors in male and female patients with primary hyperparathyroidism. J Endocrinol Invest. 2011; 35(6):548-52. DOI: 10.3275/7861. View

Hagstrom E, Lundgren E, Lithell H, Berglund L, Ljunghall S, Hellman P . Normalized dyslipidaemia after parathyroidectomy in mild primary hyperparathyroidism: population-based study over five years. Clin Endocrinol (Oxf). 2002; 56(2):253-60. DOI: 10.1046/j.0300-0664.2001.01468.x. View

Stern S, Mizrachi A, Strenov Y, Knaanie A, Benbassat C, Shpitzer T . Parathyroid adenoma: a comprehensive biochemical and histological correlative study. Clin Otolaryngol. 2016; 42(2):381-386. DOI: 10.1111/coa.12761. View

Jorde R, Sundsfjord J, Fitzgerald P, Bonaa K . Serum calcium and cardiovascular risk factors and diseases: the Tromsø study. Hypertension. 1999; 34(3):484-90. DOI: 10.1161/01.hyp.34.3.484. View

Moosgaard B, Vestergaard P, Heickendorff L, Melsen F, Christiansen P, Mosekilde L . Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: a cross-sectional study. Eur J Endocrinol. 2006; 155(2):237-44. DOI: 10.1530/eje.1.02197. View

Tanaka R, Tsushima T, Murakami H, SHIZUME K, Obara T . Insulin-like growth factor I receptors and insulin-like growth factor-binding proteins in human parathyroid tumors. World J Surg. 1994; 18(4):635-41; discussion 641-2. DOI: 10.1007/BF00353784. View

Reis J, von Muhlen D, Miller 3rd E . Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur J Endocrinol. 2008; 159(1):41-8. DOI: 10.1530/EJE-08-0072. View

Huang C, Shapses S, Wang X . Association of plasma parathyroid hormone with metabolic syndrome and risk for cardiovascular disease. Endocr Pract. 2013; 19(4):712-7. DOI: 10.4158/EP12440.RA. View

Bilezikian J . Primary Hyperparathyroidism. J Clin Endocrinol Metab. 2018; 103(11):3993-4004. PMC: 6182311. DOI: 10.1210/jc.2018-01225. View

10.

Mendoza-Zubieta V, Gonzalez-Villasenor G, Vargas-Ortega G, Gonzalez B, Ramirez-Renteria C, Mercado M . High prevalence of metabolic syndrome in a mestizo group of adult patients with primary hyperparathyroidism (PHPT). BMC Endocr Disord. 2015; 15:16. PMC: 4415358. DOI: 10.1186/s12902-015-0014-5. View

11.

Wang X, Sheng Z, Meng L, Su C, Trooskin S, Shapses S . 25-Hydroxyvitamin D and Vitamin D Binding Protein Levels in Patients With Primary Hyperparathyroidism Before and After Parathyroidectomy. Front Endocrinol (Lausanne). 2019; 10:171. PMC: 6446311. DOI: 10.3389/fendo.2019.00171. View

12.

Nam S, Lee E, Kim K, Cha B, Song Y, Lim S . Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes Relat Metab Disord. 1997; 21(5):355-9. DOI: 10.1038/sj.ijo.0800412. View

13.

Mozes G, Curlee K, Rowland C, van Heerden J, Thompson G, Grant C . The predictive value of laboratory findings in patients with primary hyperparathyroidism. J Am Coll Surg. 2002; 194(2):126-30. DOI: 10.1016/s1072-7515(01)01139-5. View

14.

Al-Hraishawi H, Dellatore P, Cai X, Wang X . Intact parathyroid hormone levels and primary hyperparathyroidism. Endocr Res. 2017; 42(3):241-245. DOI: 10.1080/07435800.2017.1292528. View

15.

Wang X, Shapses S, Al-Hraishawi H . FREE AND BIOAVAILABLE 25-HYDROXYVITAMIN D LEVELS IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM. Endocr Pract. 2016; 23(1):66-71. DOI: 10.4158/EP161434.OR. View

16.

Wareham N, Byrne C, Carr C, Day N, Boucher B, Hales C . Glucose intolerance is associated with altered calcium homeostasis: a possible link between increased serum calcium concentration and cardiovascular disease mortality. Metabolism. 1997; 46(10):1171-7. DOI: 10.1016/s0026-0495(97)90212-2. View

17.

Adam M, Untch B, Danko M, Stinnett S, Dixit D, Koh J . Severe obesity is associated with symptomatic presentation, higher parathyroid hormone levels, and increased gland weight in primary hyperparathyroidism. J Clin Endocrinol Metab. 2010; 95(11):4917-24. PMC: 3205600. DOI: 10.1210/jc.2010-0666. View

18.

Bilezikian J, Brandi M, Eastell R, Silverberg S, Udelsman R, Marcocci C . Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2014; 99(10):3561-9. PMC: 5393490. DOI: 10.1210/jc.2014-1413. View

19.

Rao D, Honasoge M, Divine G, Phillips E, Lee M, Ansari M . Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. J Clin Endocrinol Metab. 2000; 85(3):1054-8. DOI: 10.1210/jcem.85.3.6440. View

20.

Sukumar D, Partridge N, Wang X, Shapses S . The high serum monocyte chemoattractant protein-1 in obesity is influenced by high parathyroid hormone and not adiposity. J Clin Endocrinol Metab. 2011; 96(6):1852-8. PMC: 3206398. DOI: 10.1210/jc.2010-2781. View